Xcout Intel
Merus N.V.
Merus N.V. is a clinical-stage oncology company that discovers and develops antibody treatments for cancer using its proprietary Multiclonics platform. The company serves patients with cancer by advancing innovative therapeutic pipelines. Merus operates as part of Genmab.
Subscribe to see Merus N.V.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Merus N.V. at a glance
Merus N.V. is a biotechnology company headquartered in Netherlands. It has raised at least $181.3M across the 5 funding rounds on record. Its most recent funding round raised $11.5M in July 2020. Xcout tracks 4 named people at Merus N.V., including Jan G.J. van de Winkel, Ph.D. (Executive Director and Chief Executive Officer).
Merus N.V. leadership
- Jan G.J. van de Winkel, Ph.D.Executive Director and Chief Executive Officer
- Anthony PaganoNon-Executive Director
- Greg MuellerNon-Executive Director
- Martine J. van Vugt, Ph.D.Non-Executive Director
Merus N.V. funding rounds
At least $181.3M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $11.5M | 5 named | |
| SEC Form D filing | $15M | — | |
| SEC Form D filing | $55.8M | — | |
| SEC Form D filing | $80M | — | |
| Series A | $19M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Get Merus N.V.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Merus N.V. in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access